Sepsis & infection

Antianaerobic Antibiotics, Gut Microbiota, and Sepsis-associated Acute Kidney Injury

Am J Respir Crit Care MedPublished Retrospective cohort study with instrumental variable analyses, matched case-control study and murine experimental study

Authors' conclusion

Anti-anaerobic antibiotics are associated with increased risk of AKI in sepsis, potentially via modulation of the gut microbiome.

Study context

Population
Patients with sepsisretrospective cohort
Participants
12,776 patients
Comparison
Early anti-anaerobic antibiotics vs none
Outcome
Sepsis-associated AKI incidence
Methodological detailsinstrumental variable analysis (2015-16 piperacillin-tazobactam shortage), murine model
  • Instrumental variable analysis (2015-16 piperacillin-tazobactam shortage)
  • Murine model

Main finding

As reported in the abstract

Sepsis-associated AKI

Early anti-anaerobic antibiotics independently associated with increased risk of sepsis-associated acute kidney injury (AKI)

61%

95% CI 37%–92%

Observational data: associations, not effects.

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Antianaerobic Antibiotics, Gut Microbiota, and Sepsis-associated Acute Kidney Injury. Am J Respir Crit Care Med. Published 30 July 2025. doi:10.1164/rccm.202411-2281oc

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.